Other languages Orexo AB

Equities

ORX

SE0000736415

Market Closed - Nasdaq Stockholm Other stock markets 11:18:49 2024-05-21 am EDT			5-day change	1st Jan Change
21.55 ^SEK	-5.07%		+10.51%	+39.39%

May. 08	Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024
Apr. 17	Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US	Apr. 17
Sweden's Orexo Set for Early Redemption of Bonds Due 2025	Apr. 02
Orexo AB Announces Board Resignations	Mar. 22
Orexo Issues SEK500 Million Social Bonds, Closes Tender Offer	Mar. 14
Orexo Plans SEK500 Million New Social Bond Issuance, Tender Offer	Mar. 08
Orexo, Swedish Orphan Biovitrum to Further Explore AmorphOX Combination	Feb. 12
Orexo AB (Publ.) and Swedish Orphan Biovitrum AB (publ.) Agrees to Advance Feasibility Study with Amorphox	Feb. 12
Orexo AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08
US FDA Approves New Drug Application for Orexo's Opioid Overdose Rescue Medication	Nov. 28
Orexo AB Announces FDA Acceptance of New Drug Application Filing for OX124	Nov. 28
Orexo AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02
Orexo AB Announces Changes in the Board of Directors	23-10-27
Orexo AB Announces Nomination Committee Appointments	23-10-26
Orexo AB Announces Resignation of Robin Evers as A Board Member	23-10-26
Orexo's Opioid Use Disorder Drug Study Shows Unexpectedly High Treatment Response Rates	23-10-11
Orexo AB Announces Data from the MODIA Study Evaluating Impact on Use of Illicit Opioids	23-10-11
Orexo AB Announces Henrik Kjær Hansen Will Resign from the Board of Directors	23-10-02
Orexo Files New US Drug Application for Opioid Overdose Medication	23-09-18
Orexo AB (publ.) Submits New Drug Application to FDA for OX124, a High-Dose Rescue Medication for Opioid Over Overio Overio Overio Overio	23-09-18
Orexo Obtains First US Patent for Nasal Epinephrine Product	23-08-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Orexo AB

Equities

ORX

SE0000736415

Other languages

Filters